Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NB11092717E

Novus Biologicals™ Survivin Antibody Blocking Peptide
SDP

Catalog No. NB11092717E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB11092717E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB11092717E Supplier Novus Biologicals™ Supplier No. NB11092717PEP
Add to Cart
Add to Cart

Description

A peptide to BIRC5.

Specifications

Gene ID (Entrez) 332
Species Human
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Formulation Peptide dissolved in dH2O. Contains no BSA.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB 110-92717. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias API4, apoptosis inhibitor 4, Apoptosis inhibitor survivin, baculoviral IAP repeat-containing 5, Baculoviral IAP Repeat-Containing Protein 5, BIRC5, EPR-1, IAP4, survivin variant 3 alpha
Gene Symbol BIRC5
Product Type Survivin
Quantity 0.05 mg
Regulatory Status RUO - research use only
Research Category Adaptive Immunity, Angiogenesis, Apoptosis, Astrocyte Markers, Cancer, Growth and Development, Innate Immunity, Mitotic Regulators, Phospho Specific, Stem Cells
Specific Reactivity Survivin Blocking Peptide [NB110-92717PEP] is specific for Survivin Antibody [NB110-92717] only.
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.